A new paper shows that women, particularly those early in their careers, have been disproportionately affected by NIH grant ...
A proposal in the Tennessee legislature could force CVS Health to sever a core piece of its business model or exit the state ...
A STAT investigation explores how a new company is profiting from the arbitration process in the No Surprises Act.
A recent Epic lawsuit revealed a company allegedly posed as a provider to access patient records for law firms, prompting a ...
The war in the Middle East so far has not appreciably disrupted pharmaceutical supply chains, but the conflict could do so as ...
New results on Pfizer's Lyme disease vaccine, how the Middle East conflict could strain drug supply chains, and more biotech ...
In today's Morning Rounds newsletter: the high-stakes search for a new CDC director, the impact of immigration policy on ...
Doctronic, the startup behind a provocative experiment in Utah to renew drug prescriptions with a chatbot, has raised $40 ...
Insmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung ...
An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...
An experimental treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used ...
The decline of trust in health care in the U.S. has been ongoing and was worsened by the institutional responses to the Covid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results